Verification evidence is still being completed.
Molecure
Warsaw, Poland
- Verified lead
- Marcin Jan Szumowski
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- President of the Board and Chief Executive Officer
- 2026 technical specialization
- Small-Molecule Drug Discovery
- Review cycle
- May 2026
- Full address
- Zwirki i Wigury 101, 02-089 Warsaw, Poland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Molecure management page confirming Marcin Jan Szumowski as CEO and President of the Board.
- Editorial note
- Molecure is mapped as a Polish small-molecule discovery anchor with cluster relevance across German platform and translational nodes.
Small-Molecule Drug Discovery
Clinical-stage biotech platform
Molecure is mapped as a Polish small-molecule discovery anchor with cluster relevance across German platform and translational nodes.
Molecure
Small-Molecule Drug Discovery · Clinical-stage drug discovery
Molecure is mapped as a Polish small-molecule discovery anchor with cluster relevance across German platform and translational nodes.
- Lead
- Marcin Jan Szumowski (verified ↗)
- Address
- Zwirki i Wigury 101, 02-089 Warsaw, Poland (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Clinical-stage drug discovery
- Capabilities
- Medicinal Chemistry · Fibrosis and Inflammation Programs · Oncology Target Discovery
- Founded
- 2012
- Headcount
- 51-200
- Company page (open ↗)
Marcin Jan Szumowski
President of the Board and Chief Executive Officer
Official Molecure contact page listing the headquarters and laboratories at Zwirki i Wigury 101 in Warsaw.
Open sourceClinical-stage drug discovery
Warsaw, Poland. Small-Molecule Drug Discovery. Review completed on 14 Mar 2026.
Polish and EU medicinal product oversight
Clinical-stage biotech platform
Small-Molecule Drug Discovery
Molecure is mapped as a Polish small-molecule discovery anchor with cluster relevance across German platform and translational nodes.
Molecure is mapped as a Polish small-molecule discovery anchor with cluster relevance across German platform and translational nodes.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Molecure located?
- Molecure operates from Zwirki i Wigury 101, 02-089 Warsaw, Poland, Warsaw, Poland.
- Who runs Molecure?
- Molecure is led by Marcin Jan Szumowski, President of the Board and Chief Executive Officer. Verified 14 Mar 2026.
- What does Molecure do?
- Molecure is mapped as a Polish small-molecule discovery anchor with cluster relevance across German platform and translational nodes. Core capabilities: Medicinal Chemistry, Fibrosis and Inflammation Programs, Oncology Target Discovery.
Related technical briefs
Briefs that name Warsaw as a covered market or city.
